General
publicado em 01/12/2012 às 14h00:00
   Dê o seu voto:

Drug can cause weight loss syndrome, study finds

Unicamp study evaluated changes in lipid profile of 20 overweight women treated with the drug orlistat

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Antoninho Perri/Ascom/Unicamp
Thiago Inacio Barros Lopes, author of the study.
  « Previous
next »  
Thiago Inacio Barros Lopes, author of the study.

Research of the State University of Campinas (Unicamp) with the drug orlistat, the same active ingredient in alli or xenical, indicated for the treatment of obesity, proved that the drug can alter the fatty acid profile of the human organism and that in the long term, can lead to a syndrome characterized by this deficiency.

The study, which involved 20 women attending the Research Laboratory of Metabolism and Diabetes (Limed) of Gastrocentro evaluated changes in lipid profile of overweight patients treated with this drug.

The orlistat decreased absorption of fatty acids and for metabolic analysis, promoted some changes in the level of essential fatty acids (those that the body can not produce) and other metabolites such as lactate (produced after firing of glucose for energy supply without the presence of O2), and a slight reduction of calcium from patients investigated.

These women were in their 40s, in premenopausal, with BMIs between 25 and 30. As researcher Ignatius Thiago Barros Lopes, they were chosen because the female is the gender that makes more use at the time of slimming drugs.

The use of orlistat, the author explains, prevents fat absorption, and also reduces the occurrence of some compounds with fat absorbed. The author of the study then found that the drug does not affect only the lipid profile, which involves a series of tests to determine dosages colesteral total, HDL and LDL triglycerides. The effects go beyond weight loss, such as lower rates of cholesterol.

Essential fatty acids are building blocks of fat for every cell in the body, for performing functions such as energy production, increasing metabolism and muscle growth, oxygen transport, normal cell growth and hormonal regulation, among others. With its fall, people are more prone to the appearance of syndromes. Nevertheless, Thiago notes that this problem can be easily resolved with supplementation of nutrients and measures to curb the decreased level of calcium.

By comparing their study with other literature, the chemist noticed the change in the lipid profile of fatty acids, created by orlistat, is similar to what occurs with diet restriction, where the fat level decreases. Its mechanism of action, since it is not absorbed systemically and acts only in the gastrointestinal tract such as gastric lipase inhibitor, is actually correct, admits Thiago.

This drug acts in the digestive system by preventing fat consumed is absorbed by the body and brings weight gain. It was discovered in the 1990s and blocking the absorption of up to 30% of fats ingested by inhibition of lipase enzyme responsible for the digestion of fats.

<i> information Unicamp </ i>

Source: Isaude.net
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Drug can cause weight loss syndrome, study finds
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Drug can cause weight loss syndrome, study finds


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
orlistat    slimming    fatty acids    Unicamp    Campinas State University    Research Laboratory of Metabolism and Diabetes    Limed    Gastrocentro    Thiago Inacio Barros Lopes   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.